Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration

Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration

Small cell carcinoma of the esophagus (SCCE) is a rare and highly malignant type of esophageal cancer with no standard treatment, facing challenges of resistance to conventional therapies. This study presents the cases of one extensive-stage and two limited-stage SCCE patients treated with chemoimmu...

Full description

Saved in:
Bibliographic Details
Main Authors: Junhan Wu, Xin Xia, Longlong Gong, Shujie Huang, Hongbo Zheng, Guibin Qiao, Yong Tang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Small cell carcinoma of the esophagus
neoadjuvant chemoimmunotherapy
PD-L1
CD8+ T cell
case reports
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2370085
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items